US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

8.91

-1.2300-12.13%

Pre-market: 8.990.0800+0.90%07:21 EDT

Volume:584.58K

Turnover:5.34M

Market Cap:435.57M

PE:-2.78

High:10.05

Open:10.05

Low:8.84

Close:10.14

52wk High:14.53

52wk Low:2.22

Shares:48.89M

Float Shares:19.14M

Volume Ratio:2.00

T/O Rate:3.05%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2084

EPS(LYR):-3.4309

ROE:-36.58%

ROA:-22.34%

PB:1.25

PE(LYR):-2.60

Loading ...

Overview Company News Filings

Needham Sticks to Its Buy Rating for Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics highlights AlloNK data presented at EULAR 2026

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

Major Investor Makes Bold Move Into Artiva Biotherapeutics Stock

GC Corp acquires USD 12.5 million of Artiva Biotherapeutics common shares

Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV) and Phreesia (PHR)

Artiva says AB-101 plus rituximab posts 71% ACR50 response in refractory RA study

Artiva Biotherapeutics Announces Multiple Allonk® Data Presentations at Eular 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous Car T-Cell Therapy in Rheumatologic Diseases

THOMSON REUTERS

Artiva Biotherapeutics Announces Major Executive Leadership Transitions

Artiva Biotherapeutics Inc - Thad Huston to Separate as CFO Effective May 22, 2026 - SEC Filing

THOMSON REUTERS

Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development

RA Capital Management reports Artiva Biotherapeutics share buy worth $75 million

Artiva Biotherapeutics price target raised to $41 from $18 at Needham

Needham Remains a Buy on Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics Is Maintained at Outperform by Wedbush

Cantor Fitzgerald Remains a Buy on Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics Inc : Wedbush Raises Target Price to $40 From $23

THOMSON REUTERS

Tyler Van Buren Reiterates Buy on Artiva, Citing Strong AlloNK RA Efficacy and Funded Path to Registrational Trial

U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/ARTV/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ARTV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","market":"US","secType":"STK","nameCN":"Artiva Biotherapeutics, Inc.","latestPrice":8.91,"timestamp":1789502400000,"preClose":10.14,"halted":0,"volume":584582,"hourTrading":{"tag":"盘前","latestPrice":8.99,"preClose":8.91,"latestTime":"07:21 EDT","volume":112,"amount":1007.3743680000001,"timestamp":1789557665668,"change":0.08,"changeRate":0.008979,"amplitude":0.004624},"delay":0,"changeRate":-0.12130177514792903,"floatShares":19139398,"shares":48885777,"eps":-3.20842,"marketStatus":"Pre-Mkt","change":-1.23,"latestTime":"09-16 07:29:57 EDT","open":10.05,"high":10.05,"low":8.84,"amount":5339671.366939999,"amplitude":0.119329,"askPrice":9.2,"askSize":200,"bidPrice":7.81,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-3.20842,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"listingDate":1721361600000,"exchange":"NASDAQ","adjPreClose":8.91,"preHourTrading":{"tag":"盘前","latestPrice":8.99,"preClose":8.91,"latestTime":"07:21 EDT","volume":112,"amount":1007.3743680000001,"timestamp":1789557665668,"change":0.08,"changeRate":0.008979,"amplitude":0.004624},"postHourTrading":{"tag":"盘后","latestPrice":8.78,"preClose":8.91,"latestTime":"19:30 EDT","volume":7471,"amount":65975.6579,"timestamp":1789515006072,"change":-0.13,"changeRate":-0.01459,"amplitude":0.025814},"volumeRatio":2.0036207483593547,"impliedVol":1.4405,"impliedVolPercentile":0.7692},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTV\",,,,,undefined,":{"symbol":"ARTV","floatShares":19139398,"roa":"-22.34%","roe":"-36.58%","lyrEps":-3.430895,"volumeRatio":2.0036207483593547,"shares":48885777,"dividePrice":0,"high":10.05,"amplitude":0.119329,"preClose":10.14,"low":8.84,"week52Low":2.22,"pbRate":"1.25","week52High":14.53,"institutionHeld":0,"latestPrice":8.91,"committee":-0.333333,"eps":-3.20842,"divideRate":0,"volume":584582,"delay":0,"ttmEps":-3.20842,"open":10.05,"prevYearClose":4.29,"prevWeekClose":10.22,"prevMonthClose":11.3,"prevQuarterClose":9.7,"fiveDayClose":10.88,"twentyDayClose":11.74,"sixtyDayClose":9.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"ARTV","fiscalQuarterEnding":"2026/06","expectedEps":-0.64,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.63},{"market":"US","date":"2026-05-08","symbol":"ARTV","fiscalQuarterEnding":"2026/03","expectedEps":-0.88,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2026-03-10","symbol":"ARTV","fiscalQuarterEnding":"2025/12","expectedEps":-0.87,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"post","actualEps":-0.84},{"market":"US","date":"2025-11-12","symbol":"ARTV","fiscalQuarterEnding":"2025/09","expectedEps":-0.92,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.88},{"market":"US","date":"2025-08-06","symbol":"ARTV","fiscalQuarterEnding":"2025/06","expectedEps":-0.84,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.87}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1735617600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARTV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARTV","date":"2026-09-15","current":-2.777068,"percent":0.214015,"low":-11.820615,"twenty":-5.584824,"median":-1.779155,"eighty":-0.949306,"high":-0.499349,"avg":-3.319241,"sd":2.968782,"marketCap":495745826},"quantilePoints":[{"date":"2024-08-02","current":-10.391793,"twenty":-10.391793,"median":-10.391793,"eighty":-10.391793,"marketCap":269833291},{"date":"2024-08-09","current":-9.862789,"twenty":-10.391793,"median":-10.042112,"eighty":-9.943484,"marketCap":256097171},{"date":"2024-08-16","current":-10.185571,"twenty":-10.248334,"median":-10.131774,"eighty":-9.95245,"marketCap":264478532},{"date":"2024-08-23","current":-8.939273,"twenty":-10.248334,"median":-10.051078,"eighty":-9.342751,"marketCap":232117163},{"date":"2024-08-30","current":-8.088598,"twenty":-10.185571,"median":-9.943484,"eighty":-9.046867,"marketCap":263081639},{"date":"2024-09-06","current":-8.893463,"twenty":-10.142533,"median":-9.800025,"eighty":-8.930111,"marketCap":289259885},{"date":"2024-09-13","current":-8.019798,"twenty":-10.131774,"median":-9.459311,"eighty":-8.763533,"marketCap":260843926},{"date":"2024-09-20","current":-8.759053,"twenty":-10.07439,"median":-9.028935,"eighty":-8.450238,"marketCap":284888199},{"date":"2024-09-27","current":-9.946342,"twenty":-10.07439,"median":-9.323455,"eighty":-8.581333,"marketCap":323504758},{"date":"2024-10-04","current":-11.499524,"twenty":-10.277026,"median":-9.57298,"eighty":-8.727691,"marketCap":374022017},{"date":"2024-10-11","current":-10.566121,"twenty":-10.505561,"median":-9.728296,"eighty":-8.794895,"marketCap":343663087},{"date":"2024-10-18","current":-9.543111,"twenty":-10.587029,"median":-9.800025,"eighty":-8.869568,"marketCap":310389700},{"date":"2024-10-25","current":-7.586699,"twenty":-10.505561,"median":-9.574426,"eighty":-8.581333,"marketCap":246757383},{"date":"2024-10-31","current":-7.579232,"twenty":-10.485041,"median":-9.464706,"eighty":-8.226879,"marketCap":246514511},{"date":"2024-11-08","current":-10.424244,"twenty":-10.485041,"median":-9.3863,"eighty":-8.226879,"marketCap":339048530},{"date":"2024-11-15","current":-4.166082,"twenty":-10.46953,"median":-9.378833,"eighty":-8.149728,"marketCap":255280837},{"date":"2024-11-22","current":-4.310765,"twenty":-10.439178,"median":-9.30416,"eighty":-7.969021,"marketCap":264146442},{"date":"2024-11-29","current":-5.065892,"twenty":-10.411264,"median":-9.046867,"eighty":-7.81669,"marketCap":310417611},{"date":"2024-12-06","current":-4.598149,"twenty":-10.334409,"median":-8.970887,"eighty":-7.365669,"marketCap":281756204},{"date":"2024-12-13","current":-4.233469,"twenty":-10.223229,"median":-8.939273,"eighty":-5.058757,"marketCap":259410023},{"date":"2024-12-20","current":-3.963922,"twenty":-10.173512,"median":-8.885996,"eighty":-4.852633,"marketCap":242893280},{"date":"2024-12-27","current":-4.17401,"twenty":-10.150694,"median":-8.781454,"eighty":-4.667914,"marketCap":255766623},{"date":"2025-01-03","current":-3.95203,"twenty":-10.131774,"median":-8.549971,"eighty":-4.598149,"marketCap":242164600},{"date":"2025-01-10","current":-4.066984,"twenty":-10.131774,"median":-8.396892,"eighty":-4.398368,"marketCap":249208505},{"date":"2025-01-17","current":-2.687539,"twenty":-10.07439,"median":-8.17661,"eighty":-4.337719,"marketCap":164681643},{"date":"2025-01-24","current":-2.477451,"twenty":-10.049285,"median":-8.109405,"eighty":-4.224748,"marketCap":151808300},{"date":"2025-01-31","current":-2.140518,"twenty":-10.011532,"median":-8.012331,"eighty":-4.193829,"marketCap":131162371},{"date":"2025-02-07","current":-1.823404,"twenty":-9.967928,"median":-7.881014,"eighty":-4.108209,"marketCap":111730908},{"date":"2025-02-14","current":-1.589533,"twenty":-9.948785,"median":-7.698708,"eighty":-3.978192,"marketCap":97400205},{"date":"2025-02-21","current":-1.502326,"twenty":-9.945199,"median":-7.508293,"eighty":-3.804572,"marketCap":92056553},{"date":"2025-02-28","current":-1.478543,"twenty":-9.911206,"median":-5.18038,"eighty":-2.77871,"marketCap":90599193},{"date":"2025-03-07","current":-2.0216,"twenty":-9.837683,"median":-5.059946,"eighty":-2.521847,"marketCap":123875572},{"date":"2025-03-14","current":-2.219796,"twenty":-9.795827,"median":-4.998506,"eighty":-2.343471,"marketCap":136020236},{"date":"2025-03-21","current":-1.601424,"twenty":-9.736345,"median":-4.76067,"eighty":-2.165887,"marketCap":98128885},{"date":"2025-03-28","current":-1.319282,"twenty":-9.624289,"median":-4.665536,"eighty":-2.054897,"marketCap":86245441},{"date":"2025-04-04","current":-0.946604,"twenty":-9.574715,"median":-4.606077,"eighty":-1.965312,"marketCap":61882322},{"date":"2025-04-11","current":-0.685729,"twenty":-9.561032,"median":-4.439593,"eighty":-1.797242,"marketCap":44828138},{"date":"2025-04-17","current":-0.857161,"twenty":-9.511749,"median":-4.37617,"eighty":-1.744126,"marketCap":56035173},{"date":"2025-04-25","current":-0.913063,"twenty":-9.383313,"median":-4.344458,"eighty":-1.606181,"marketCap":59689641},{"date":"2025-05-02","current":-0.883248,"twenty":-9.365642,"median":-4.233469,"eighty":-1.560992,"marketCap":57740592},{"date":"2025-05-09","current":-0.740531,"twenty":-9.335033,"median":-4.213649,"eighty":-1.495984,"marketCap":53111599},{"date":"2025-05-16","current":-0.723546,"twenty":-9.26085,"median":-4.193829,"eighty":-1.480232,"marketCap":51893443},{"date":"2025-05-23","current":-0.672592,"twenty":-9.079462,"median":-4.170046,"eighty":-1.376675,"marketCap":48238975},{"date":"2025-05-30","current":-0.696371,"twenty":-9.046867,"median":-4.104641,"eighty":-1.177664,"marketCap":49944393},{"date":"2025-06-06","current":-0.665798,"twenty":-9.028935,"median":-3.995633,"eighty":-0.946604,"marketCap":47751713},{"date":"2025-06-13","current":-0.696371,"twenty":-8.975602,"median":-3.957976,"eighty":-0.913063,"marketCap":49944393},{"date":"2025-06-20","current":-0.570684,"twenty":-8.968058,"median":-3.829149,"eighty":-0.909336,"marketCap":40930039},{"date":"2025-06-27","current":-0.533318,"twenty":-8.961769,"median":-2.822312,"eighty":-0.881757,"marketCap":38250096},{"date":"2025-07-03","current":-0.546906,"twenty":-8.947831,"median":-2.762854,"eighty":-0.830328,"marketCap":39224621},{"date":"2025-07-11","current":-0.60805,"twenty":-8.911787,"median":-2.592405,"eighty":-0.73948,"marketCap":43609983},{"date":"2025-07-18","current":-0.879805,"twenty":-8.888983,"median":-2.477451,"eighty":-0.736237,"marketCap":63100478},{"date":"2025-07-25","current":-1.168544,"twenty":-8.885996,"median":-2.34466,"eighty":-0.73948,"marketCap":83809129},{"date":"2025-08-01","current":-1.019079,"twenty":-8.836712,"median":-2.219796,"eighty":-0.740531,"marketCap":73089357},{"date":"2025-08-08","current":-0.856075,"twenty":-8.776974,"median":-2.136554,"eighty":-0.74119,"marketCap":64318634},{"date":"2025-08-15","current":-0.877783,"twenty":-8.664966,"median":-2.104843,"eighty":-0.766227,"marketCap":65949557},{"date":"2025-08-22","current":-0.90054,"twenty":-8.539516,"median":-2.017636,"eighty":-0.794855,"marketCap":67659360},{"date":"2025-08-29","current":-1.027331,"twenty":-8.461857,"median":-1.938358,"eighty":-0.806285,"marketCap":77185407},{"date":"2025-09-05","current":-1.011075,"twenty":-8.405106,"median":-1.906646,"eighty":-0.809828,"marketCap":75964119},{"date":"2025-09-12","current":-0.864778,"twenty":-8.31765,"median":-1.769891,"eighty":-0.816568,"marketCap":64972526},{"date":"2025-09-19","current":-0.773749,"twenty":-8.226879,"median":-1.740162,"eighty":-0.790778,"marketCap":58133313},{"date":"2025-09-26","current":-0.978565,"twenty":-8.17661,"median":-1.635118,"eighty":-0.805192,"marketCap":73521543},{"date":"2025-10-03","current":-0.959059,"twenty":-8.149728,"median":-1.601424,"eighty":-0.809828,"marketCap":72055997},{"date":"2025-10-10","current":-0.975314,"twenty":-8.101082,"median":-1.571695,"eighty":-0.816568,"marketCap":73277286},{"date":"2025-10-17","current":-0.90054,"twenty":-8.061078,"median":-1.530074,"eighty":-0.825779,"marketCap":67659360},{"date":"2025-10-24","current":-1.573506,"twenty":-8.013824,"median":-1.539983,"eighty":-0.830317,"marketCap":118220688},{"date":"2025-10-31","current":-1.280912,"twenty":-7.969021,"median":-1.537745,"eighty":-0.833281,"marketCap":96237502},{"date":"2025-11-07","current":-1.11836,"twenty":-7.90156,"median":-1.498363,"eighty":-0.837688,"marketCap":84024621},{"date":"2025-11-14","current":-1.102105,"twenty":-7.858868,"median":-1.490435,"eighty":-0.847643,"marketCap":82803333},{"date":"2025-11-21","current":-0.982565,"twenty":-7.819676,"median":-1.476561,"eighty":-0.856509,"marketCap":77807345},{"date":"2025-11-28","current":-1.16544,"twenty":-7.765913,"median":-1.457948,"eighty":-0.858684,"marketCap":92288839},{"date":"2025-12-05","current":-1.170089,"twenty":-7.585206,"median":-1.427209,"eighty":-0.865066,"marketCap":92657012},{"date":"2025-12-12","current":-0.973266,"twenty":-7.550856,"median":-1.356118,"eighty":-0.866579,"marketCap":77070998},{"date":"2025-12-19","current":-1.441302,"twenty":-7.413459,"median":-1.35655,"eighty":-0.869582,"marketCap":114133803},{"date":"2025-12-26","current":-1.332817,"twenty":-7.317879,"median":-1.35655,"eighty":-0.875795,"marketCap":105543087},{"date":"2026-01-02","current":-1.329717,"twenty":-5.60788,"median":-1.355686,"eighty":-0.876285,"marketCap":105297638},{"date":"2026-01-09","current":-1.419605,"twenty":-5.08879,"median":-1.356118,"eighty":-0.877508,"marketCap":112415660},{"date":"2026-01-16","current":-1.38241,"twenty":-5.065892,"median":-1.373111,"eighty":-0.877783,"marketCap":109470271},{"date":"2026-01-23","current":-1.534289,"twenty":-5.058757,"median":-1.38241,"eighty":-0.877783,"marketCap":121497274},{"date":"2026-01-30","current":-1.286323,"twenty":-5.046865,"median":-1.38396,"eighty":-0.878996,"marketCap":101861351},{"date":"2026-02-06","current":-1.199535,"twenty":-5.015947,"median":-1.373111,"eighty":-0.880542,"marketCap":94988778},{"date":"2026-02-13","current":-1.23673,"twenty":-4.922398,"median":-1.361731,"eighty":-0.882362,"marketCap":97934166},{"date":"2026-02-20","current":-1.404107,"twenty":-4.858976,"median":-1.356118,"eighty":-0.88623,"marketCap":111188415},{"date":"2026-02-27","current":-1.689268,"twenty":-4.776526,"median":-1.370012,"eighty":-0.890736,"marketCap":133769726},{"date":"2026-03-06","current":-1.779155,"twenty":-4.679806,"median":-1.38241,"eighty":-0.892087,"marketCap":140887748},{"date":"2026-03-13","current":-1.989358,"twenty":-4.672671,"median":-1.404107,"eighty":-0.894194,"marketCap":166837536},{"date":"2026-03-20","current":-1.626853,"twenty":-4.654437,"median":-1.418531,"eighty":-0.895573,"marketCap":136436029},{"date":"2026-03-27","current":-1.520754,"twenty":-4.628275,"median":-1.425804,"eighty":-0.898589,"marketCap":127538027},{"date":"2026-04-02","current":-1.989358,"twenty":-4.610834,"median":-1.432003,"eighty":-0.90054,"marketCap":166837536},{"date":"2026-04-10","current":-2.004094,"twenty":-4.574366,"median":-1.4506,"eighty":-0.90119,"marketCap":168073369},{"date":"2026-04-17","current":-3.569056,"twenty":-4.471304,"median":-1.457173,"eighty":-0.904441,"marketCap":299318897},{"date":"2026-04-24","current":-3.330333,"twenty":-4.432458,"median":-1.470747,"eighty":-0.907501,"marketCap":279298393},{"date":"2026-05-01","current":-3.01793,"twenty":-4.398368,"median":-1.476546,"eighty":-0.909336,"marketCap":253098721},{"date":"2026-05-08","current":-3.689891,"twenty":-4.369828,"median":-1.481596,"eighty":-0.910081,"marketCap":309452733},{"date":"2026-05-15","current":-3.031745,"twenty":-4.344458,"median":-1.487795,"eighty":-0.913063,"marketCap":263974056},{"date":"2026-05-22","current":-4.458708,"twenty":-4.432458,"median":-1.494399,"eighty":-0.913063,"marketCap":388219702},{"date":"2026-05-29","current":-4.246654,"twenty":-4.403917,"median":-1.50281,"eighty":-0.913063,"marketCap":369756186},{"date":"2026-06-05","current":-4.285717,"twenty":-4.403917,"median":-1.512592,"eighty":-0.913063,"marketCap":373157360},{"date":"2026-06-12","current":-4.464288,"twenty":-4.403917,"median":-1.532182,"eighty":-0.913063,"marketCap":388705584},{"date":"2026-06-18","current":-5.546878,"twenty":-4.459824,"median":-1.539565,"eighty":-0.913448,"marketCap":482966688},{"date":"2026-06-26","current":-4.927458,"twenty":-4.618762,"median":-1.553857,"eighty":-0.916145,"marketCap":429033788},{"date":"2026-07-02","current":-5.468753,"twenty":-4.679014,"median":-1.559086,"eighty":-0.919028,"marketCap":476164340},{"date":"2026-07-10","current":-5.251119,"twenty":-4.852633,"median":-1.578076,"eighty":-0.922185,"marketCap":457214943},{"date":"2026-07-17","current":-5.044646,"twenty":-4.98936,"median":-1.593497,"eighty":-0.929149,"marketCap":439237309},{"date":"2026-07-24","current":-5.652905,"twenty":-5.058757,"median":-1.601424,"eighty":-0.93305,"marketCap":492198445},{"date":"2026-07-31","current":-5.820316,"twenty":-5.116075,"median":-1.607696,"eighty":-0.93435,"marketCap":506774905},{"date":"2026-08-07","current":-6.195168,"twenty":-5.189342,"median":-1.626853,"eighty":-0.936301,"marketCap":562651332},{"date":"2026-08-14","current":-6.082936,"twenty":-5.239958,"median":-1.667148,"eighty":-0.936301,"marketCap":552458367},{"date":"2026-08-21","current":-5.996806,"twenty":-5.366075,"median":-1.692595,"eighty":-0.938902,"marketCap":544635947},{"date":"2026-08-28","current":-6.427457,"twenty":-5.453128,"median":-1.724769,"eighty":-0.944323,"marketCap":583748044},{"date":"2026-09-04","current":-5.988732,"twenty":-5.513396,"median":-1.759981,"eighty":-0.947685,"marketCap":543902596},{"date":"2026-09-11","current":-5.609221,"twenty":-5.589289,"median":-1.769857,"eighty":-0.949306,"marketCap":509435060},{"date":"2026-09-15","current":-5.458493,"twenty":-5.584824,"median":-1.779155,"eighty":-0.949306,"marketCap":495745826}],"updateTime":1789558197709},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARTV\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641543839","title":"Needham Sticks to Its Buy Rating for Artiva Biotherapeutics, Inc. (ARTV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641543839","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641543839?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:55","pubTimestamp":1780930543,"startTime":"0","endTime":"0","summary":"Needham analyst Gil Blum reiterated a Buy rating on Artiva Biotherapeutics, Inc. today and set a price target of $41.00. Blum covers the Healthcare...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/needham-sticks-to-its-buy-rating-for-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/needham-sticks-to-its-buy-rating-for-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641485733","title":"Artiva Biotherapeutics highlights AlloNK data presented at EULAR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2641485733","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641485733?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:40","pubTimestamp":1780915249,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics (ARTV) highlighted clinical, safety and translational data for AlloNK, also known as AB-101, an allogeneic, off-the-shelf, n...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-highlights-allonk-data-presented-at-eular-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-highlights-allonk-data-presented-at-eular-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641450485","title":"Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2641450485","media":"GlobeNewswire","labels":["policyRegulatory","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641450485?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:30","pubTimestamp":1780914600,"startTime":"0","endTime":"0","summary":"Multiple EULAR presentations reinforce potential of AlloNK to drive deep B-cell depletion and meaningful clinical responses across refractory rheumatoid arthritis, Sjgren disease and systemic sclerosi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/08/3307910/0/en/Artiva-Biotherapeutics-Highlights-AlloNK-Data-Presented-at-EULAR-2026-FDA-RMAT-Designation-in-Refractory-Rheumatoid-Arthritis-and-Webcast-Today.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4187","LU0963586101.USD","ARTV","RA","BK4585","BK4006","IE0031619046.USD","BK4588","LU2065731478.USD","IE00B19Z4B17.USD","CRS","BK4139","LABU","IE00B66KJ199.SGD","IE00B7SZL793.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639564385","title":"Major Investor Makes Bold Move Into Artiva Biotherapeutics Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2639564385","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639564385?lang=en_us&edition=fundamental","pubTime":"2026-05-29 10:15","pubTimestamp":1780020954,"startTime":"0","endTime":"0","summary":"New insider activity at Artiva Biotherapeutics, Inc. ( ($ARTV) ) has taken place on May 28, 2026. Significant shareholder GC Corp. has made a major...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-investor-makes-bold-move-into-artiva-biotherapeutics-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-investor-makes-bold-move-into-artiva-biotherapeutics-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639619308","title":"GC Corp acquires USD 12.5 million of Artiva Biotherapeutics common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2639619308","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639619308?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:36","pubTimestamp":1780000586,"startTime":"0","endTime":"0","summary":"GC Corp. reported purchases of Artiva Biotherapeutics common stock at USD 11.52 per share, lifting its direct stake to 4,391,969 shares.GC Cell Corp, an affiliate, also bought common stock at USD 11.52, increasing its indirect holdings to 1,607,734 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL2SVXZt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GC Corp acquires USD 12.5 million of Artiva Biotherapeutics common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698121","title":"Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698121","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698121?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:00","pubTimestamp":1779969600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, May  28, 2026  (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therap","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/28/3302755/0/en/Artiva-Biotherapeutics-to-Participate-in-the-2026-Jefferies-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","ARTV","XBI","BK4581","BK4137","HCSG","LU0029874061.USD","BK4585","BK4588","BK4139","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638151269","title":"Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV) and Phreesia (PHR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638151269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638151269?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:40","pubTimestamp":1779799204,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Artiva Biotherapeutics, Inc. (ARTV) and Phreesia (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-artiva-biotherapeutics-inc-artv-and-phreesia-phr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-artiva-biotherapeutics-inc-artv-and-phreesia-phr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","LABU","LU0029874061.USD","PHR","BK4139","BK4588","BK4167","HCSG","LU0128526141.USD","BK4137","XBI","ARTV","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636086127","title":"Artiva says AB-101 plus rituximab posts 71% ACR50 response in refractory RA study","url":"https://stock-news.laohu8.com/highlight/detail?id=2636086127","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636086127?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:05","pubTimestamp":1779221150,"startTime":"0","endTime":"0","summary":"Artiva Biotherapeutics flagged new clinical data for its AB-101 allogeneic NK-cell therapy with rituximab, scheduled for presentation at the EULAR 2026 Congress in London on June 3–6.The late-breaking oral presentation is set to show that the regimen produced strong clinical responses in rheumatologic diseases, described as comparable to outcomes reported with autologous CAR T-cell therapy.Additional EULAR presentations are expected to highlight durable benefit in severe rheumatoid arthritis, an initial experience in severe Sjgren disease, deep B-cell depletion, and a safety profile characterized as favorable in immune-mediated diseases.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL1wKsMf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","SG9999014039.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","BK4588","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4585","IE00BGHQF748.EUR","ARTV","IE00BKPKM429.USD","LU0314104364.USD","BK4112","SG9999014005.SGD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4139","NDAQ","IE00BN0W2W23.USD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636861240","title":"Artiva Biotherapeutics Announces Multiple Allonk® Data Presentations at Eular 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous Car T-Cell Therapy in Rheumatologic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2636861240","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636861240?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:05","pubTimestamp":1779221101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA5DH66M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636385982","title":"Artiva Biotherapeutics Announces Major Executive Leadership Transitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2636385982","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636385982?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:30","pubTimestamp":1779193851,"startTime":"0","endTime":"0","summary":"An announcement from Artiva Biotherapeutics, Inc. ( ($ARTV) ) is now available. On May 18, 2026, Artiva Biotherapeutics announced several leadershi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/artiva-biotherapeutics-announces-major-executive-leadership-transitions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/artiva-biotherapeutics-announces-major-executive-leadership-transitions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636855086","title":"Artiva Biotherapeutics Inc - Thad Huston to Separate as CFO Effective May 22, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2636855086","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636855086?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:08","pubTimestamp":1779192525,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41W06K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636685524","title":"Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2636685524","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636685524?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:00","pubTimestamp":1779192000,"startTime":"0","endTime":"0","summary":"Veteran biotechnology executive with more than 20 years of leadership experience spanning research, clinical development, commercialization and company building Proven track record advancing multiple ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/19/3297380/0/en/Artiva-Biotherapeutics-Appoints-Veteran-Biotech-Executive-and-Drug-Developer-Diego-Miralles-M-D-as-President-and-Head-of-Research-and-Development.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XBI","RA","BK4581","ARTV","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635759039","title":"RA Capital Management reports Artiva Biotherapeutics share buy worth $75 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635759039","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635759039?lang=en_us&edition=fundamental","pubTime":"2026-05-14 05:46","pubTimestamp":1778708812,"startTime":"0","endTime":"0","summary":"RA Capital Management reported a purchase of 6,510,416 Artiva Biotherapeutics common shares at USD 11.52.Holdings in common stock rose to 15,203,995 shares, held indirectly.Filing also showed an indirect purchase of 2,170,138 Pre-Funded Warrants exercisable at USD 0.0001, priced at USD 11.52.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL4n47n7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"RA Capital Management reports Artiva Biotherapeutics share buy worth $75 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635442862","title":"Artiva Biotherapeutics price target raised to $41 from $18 at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2635442862","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635442862?lang=en_us&edition=fundamental","pubTime":"2026-05-13 02:55","pubTimestamp":1778612113,"startTime":"0","endTime":"0","summary":"Needham analyst Gil Blum raised the firm’s price target on Artiva Biotherapeutics (ARTV) to $41 from $18 and keeps a Buy rating on the shares after...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-price-target-raised-to-41-from-18-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/artiva-biotherapeutics-price-target-raised-to-41-from-18-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634121846","title":"Needham Remains a Buy on Artiva Biotherapeutics, Inc. (ARTV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634121846","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634121846?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:56","pubTimestamp":1778583390,"startTime":"0","endTime":"0","summary":"Needham analyst Gil Blum reiterated a Buy rating on Artiva Biotherapeutics, Inc. today and set a price target of $41.00. Blum covers the Healthcare...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/needham-remains-a-buy-on-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/needham-remains-a-buy-on-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","XBI","BK4581","ARTV","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634817281","title":"Artiva Biotherapeutics Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2634817281","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634817281?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:36","pubTimestamp":1778502960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARTV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 08:36 ET (12:36 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634281502","title":"Cantor Fitzgerald Remains a Buy on Artiva Biotherapeutics, Inc. (ARTV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634281502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634281502?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:34","pubTimestamp":1778502844,"startTime":"0","endTime":"0","summary":"In a report released on May 8, Joshua Schimmer from Cantor Fitzgerald maintained a Buy rating on Artiva Biotherapeutics, Inc., with a price target ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-remains-a-buy-on-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-remains-a-buy-on-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634283014","title":"Artiva Biotherapeutics Inc : Wedbush Raises Target Price to $40 From $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2634283014","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634283014?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:26","pubTimestamp":1778498791,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nFWN41O18J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634880832","title":"Tyler Van Buren Reiterates Buy on Artiva, Citing Strong AlloNK RA Efficacy and Funded Path to Registrational Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2634880832","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634880832?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:55","pubTimestamp":1778496919,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren has maintained their bullish stance on ARTV stock, giving a Buy rating on May 8. Tyler Van Buren has given his Buy...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/tyler-van-buren-reiterates-buy-on-artiva-citing-strong-allonk-ra-efficacy-and-funded-path-to-registrational-trial-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/tyler-van-buren-reiterates-buy-on-artiva-citing-strong-allonk-ra-efficacy-and-funded-path-to-registrational-trial-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV","TYL","LU1989763005.USD","BK4023","RA","BK4585","LU0390134368.USD","BK4588","LU1989773731.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634403112","title":"U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla","url":"https://stock-news.laohu8.com/highlight/detail?id=2634403112","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634403112?lang=en_us&edition=fundamental","pubTime":"2026-05-11 15:27","pubTimestamp":1778484476,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla May 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Airbnb, HII and Tesla, o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL4N41O0GT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFRU","ALB","ARTV","APO","AZTA","AMDW","CG","CRBU","ARXS","CF","AVTX","BWA","CRI","ANIP","TECH","BP","AGL","ASPN","BWXT","CPT","BAM","FRDU","AMD","AMDL","AMUU","CRC","ABNG","AIZ","ASTH","ATLC","BDX","AVB","ABNB","WHD","BOOT","CPRX","ABNY","ALBG","F","AIDX","AMPH","CTRI","BCAX","CWH","BILL","AMYY","BBIO","AFRM","CAR","AMDD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":91,"code":"91000000","status":"200"}]}}